Max Robotics — Global Service Robot Directory + US Certification

About

E. Mazzone is a leading figure in urologic oncology, with a specialized focus on robotic-assisted surgery for bladder cancer. Their most significant contribution lies in advancing the understanding of long-term outcomes following robot-assisted radical cystectomy (RARC). Mazzone’s landmark study, “Long-term oncologic outcomes of robot-assisted radical cystectomy: Update series from an high-volume robotic center beyond 10 years of follow-up,” provides critical evidence on the durability and efficacy of this minimally invasive approach, offering the field its first comprehensive look at survival and recurrence rates beyond a decade. This work, which has garnered 2 citations, underscores Mazzone’s role in validating RARC as a standard of care for muscle-invasive bladder cancer. By demonstrating that robotic techniques can achieve oncologic control comparable to open surgery while reducing morbidity, Mazzone has helped shift clinical practice toward less invasive options. Their research is instrumental for surgeons and trainees seeking to understand the real-world, long-term benefits of robotic cystectomy, solidifying Mazzone’s reputation as a pioneer in high-volume robotic centers and a key contributor to evidence-based urologic oncology.